The Cellular and Architectural Determinants of Immune Evasion and Their Impact on Response to Therapy in Classical Hodgkin Lymphoma IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT) Margaret A. Shipp, MD, Dana-Farber Cancer Institute/ Harvard Medical School Dr. Shipp is mapping the immune microenvironment in classical Hodgkin lymphoma.